申请人:Shionogi & Co., Ltd.
公开号:EP2511269A1
公开(公告)日:2012-10-17
The present invention provides, for example, a compound mentioned below as a medicament for treating or preventing the diseases induced by production, secretion or deposition of amyloid-β proteins.
A compound of the formula (I):
wherein R1, R2a, R2b, R3, R4, R5a, R5b, R6a, R6b, X, Y, Z, ring A and the dashed lines are defined in the specification,
its pharmaceutically acceptable salt or a solvate thereof.
本发明提供了例如下述化合物,作为治疗或预防由淀粉样β蛋白的产生、分泌或沉积诱发的疾病的药物。
式 (I) 的化合物:
其中 R1、R2a、R2b、R3、R4、R5a、R5b、R6a、R6b、X、Y、Z、环 A 和虚线的定义见说明书、
其药学上可接受的盐或其溶液。